Last reviewed · How we verify
Intermittent bolus infusion of levobupivacaine
Intermittent bolus infusion of levobupivacaine is a Small molecule drug developed by University Hospital, Antwerp. It is currently FDA-approved. Also known as: chirocaine.
At a glance
| Generic name | Intermittent bolus infusion of levobupivacaine |
|---|---|
| Also known as | chirocaine |
| Sponsor | University Hospital, Antwerp |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- PENG Block: Continuous Infusion vs. Programmed Intermittent Bolus in Neck of Femur Fracture (NA)
- ESP Block in VATS: Programmed Intermittent Bolus Versus Continuous Infusion on Quality of Recovery (NA)
- Postoperative Analgesia With a Catheter Under the Erector Spinae Muscle for Videothoracoscopic Lung Surgery (NA)
- Study Comparing Dural Puncture Epidural With Epidural and Combined Spinal Epidural Anesthesia for Obstetric Analgesia. (PHASE3)
- Programmed Intermittent Epidural Bolus Versus Continuous Epidural Infusion for Third Trimester Medical Termination of Pregnancy Analgesia : a Randomized Study. (PCEA-IMG) (PHASE3)
- Epidural Analgesia During Labour (PHASE3)
- Comparison of Two Methods of Administration of the Epidural, by Programmed Intermittent Bolus or Continuous Perfusion, on the Incidence of Cesarean Sections and Instrumented Deliveries in Primiparous Women (PHASE2)
- Intermittent Automated Devices for Labor Analgesia in Emilia Romagna (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Intermittent bolus infusion of levobupivacaine CI brief — competitive landscape report
- Intermittent bolus infusion of levobupivacaine updates RSS · CI watch RSS
- University Hospital, Antwerp portfolio CI
Frequently asked questions about Intermittent bolus infusion of levobupivacaine
What is Intermittent bolus infusion of levobupivacaine?
Intermittent bolus infusion of levobupivacaine is a Small molecule drug developed by University Hospital, Antwerp.
Who makes Intermittent bolus infusion of levobupivacaine?
Intermittent bolus infusion of levobupivacaine is developed and marketed by University Hospital, Antwerp (see full University Hospital, Antwerp pipeline at /company/university-hospital-antwerp).
Is Intermittent bolus infusion of levobupivacaine also known as anything else?
Intermittent bolus infusion of levobupivacaine is also known as chirocaine.
What development phase is Intermittent bolus infusion of levobupivacaine in?
Intermittent bolus infusion of levobupivacaine is FDA-approved (marketed).
Related
- Manufacturer: University Hospital, Antwerp — full pipeline
- Also known as: chirocaine
- Compare: Intermittent bolus infusion of levobupivacaine vs similar drugs
- Pricing: Intermittent bolus infusion of levobupivacaine cost, discount & access